A LinkedIn post from Doccla highlights commentary from Tom Breeze on the need to redesign commissioning and funding models to scale Proactive Care. The post emphasizes that intervening earlier in a patient’s journey can be more effective and efficient than treating conditions once they have escalated into crises.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The content suggests that value-based care structures, which reward providers for keeping patients stable at home, may be central to Doccla’s strategic positioning in digital and virtual care. For investors, this focus could indicate alignment with U.K. NHS policy goals around community-based care and reduced hospital admissions, potentially supporting demand for remote-monitoring and virtual-care solutions.
If adopted at scale, such models could create longer-term, recurring revenue opportunities tied to clinical outcomes rather than episodic activity. However, the post also implicitly underscores dependency on evolving reimbursement frameworks and commissioning decisions, which may introduce policy and implementation risk into Doccla’s growth trajectory.

